Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.
Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, Staehler M, Brugger W, Dietrich PY, Mendrzyk R, Hilf N, Schoor O, Fritsche J, Mahr A, Maurer D, Vass V, Trautwein C, Lewandrowski P, Flohr C, Pohla H, Stanczak JJ, Bronte V, Mandruzzato S, Biedermann T, Pawelec G, Derhovanessian E, Yamagishi H, Miki T, Hongo F, Takaha N, Hirakawa K, Tanaka H, Stevanovic S, Frisch J, Mayer-Mokler A, Kirner A, Rammensee HG, Reinhardt C, Singh-Jasuja H. Walter S, et al. Among authors: bronte v. Nat Med. 2012 Aug;18(8):1254-61. doi: 10.1038/nm.2883. Epub 2012 Jul 29. Nat Med. 2012. PMID: 22842478 Clinical Trial.
Part I: Vaccines for solid tumours.
Mocellin S, Mandruzzato S, Bronte V, Lise M, Nitti D. Mocellin S, et al. Among authors: bronte v. Lancet Oncol. 2004 Nov;5(11):681-9. doi: 10.1016/S1470-2045(04)01610-9. Lancet Oncol. 2004. PMID: 15522656 Review.
Cancer vaccines: pessimism in check.
Mocellin S, Mandruzzato S, Bronte V, Marincola FM. Mocellin S, et al. Among authors: bronte v. Nat Med. 2004 Dec;10(12):1278-9; author reply 1279-80. doi: 10.1038/nm1204-1278. Nat Med. 2004. PMID: 15580242 No abstract available.
Myeloid-derived suppressor cell heterogeneity in human cancers.
Solito S, Marigo I, Pinton L, Damuzzo V, Mandruzzato S, Bronte V. Solito S, et al. Among authors: bronte v. Ann N Y Acad Sci. 2014 Jun;1319:47-65. doi: 10.1111/nyas.12469. Ann N Y Acad Sci. 2014. PMID: 24965257 Review.
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.
Mandruzzato S, Brandau S, Britten CM, Bronte V, Damuzzo V, Gouttefangeas C, Maurer D, Ottensmeier C, van der Burg SH, Welters MJ, Walter S. Mandruzzato S, et al. Among authors: bronte v. Cancer Immunol Immunother. 2016 Feb;65(2):161-9. doi: 10.1007/s00262-015-1782-5. Epub 2016 Jan 4. Cancer Immunol Immunother. 2016. PMID: 26728481 Free PMC article.
230 results